Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus midazolam for pediatric dental sedation
ChiCTR2300074131Phase 4Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Air Force Medical University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and midazolam in Maxillofacial Disorders (2 arms), sponsored by The Third Affiliated Hospital of Air Force Medical University. Primary endpoints: Sedation success rate, Time to readiness for discharge after the end of the procedure and 1 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
remimazolammidazolam
03
Conditions
Maxillofacial Disorders
Beyond the preview
Go deeper on ChiCTR2300074131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074131.